Grisham RN, Vergote I, Banerjee S, Drill E, et al. Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer. Clin Cancer Res 2023 Aug 15:CCR-23-0621. doi: 10.1158/1078-0432.CCR-23-0621.
PMID: 37581616